Byrne Asset Management LLC Pet Iq, Inc. Transaction History

Byrne Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$9.32 - $12.58 $19,469 - $26,279	-2,089 Reduced 56.02%	1,640 $18,000
Q4 2022 Jan 30, 2023	SELL	$6.82 - $12.07 $341 - $603	-50 Reduced 1.32%	3,729 $34,000
Q3 2022 Oct 19, 2022	BUY	$6.9 - $18.16 $11,516 - $30,309	1,669 Added 79.1%	3,779 $26,000
Q2 2022 Jul 20, 2022	BUY	$14.09 - $25.12 $4,508 - $8,038	320 Added 17.88%	2,110 $39,000
Q1 2022 Apr 05, 2022	BUY	$17.92 - $24.4 $9,820 - $13,371	548 Added 44.12%	1,790 $44,000
Q4 2021 Feb 22, 2022	BUY	$19.97 - $25.91 $24,802 - $32,180	1,242 New	1,242 $28,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Byrne Asset Management LLC with notifications on news.